ID   ICGi016-A
AC   CVCL_UF64
SY   iTAF9-11; iTaf9-11; ICAGi001-A
DR   BioSamples; SAMEA5230331
DR   hPSCreg; ICGi016-A
RX   PubMed=30616144;
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Derived from sampling site: Skin.
DI   NCIt; C156309; Mental retardation, autosomal dominant 39
DI   ORDO; Orphanet_178469; Autosomal dominant non-syndromic intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens
SX   Female
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 12-03-20; Version: 4
//
RX   PubMed=30616144; DOI=10.1016/j.scr.2018.101377;
RA   Khabarova A.A., Pristyazhnyuk I.E., Nikitina T.V., Gayner T.A.,
RA   Torkhova N.B., Skryabin N.A., Kashevarova A.A., Babushkina N.P.,
RA   Markova Z.G., Minzhenkova M.E., Nazarenko L.P., Shilova N.V.,
RA   Shorina A.R., Lebedev I.N., Serov O.L.;
RT   "Induced pluripotent stem cell line, ICAGi001-A, derived from human
RT   skin fibroblasts of a patient with 2p25.3 deletion and 2p25.3-p23.3
RT   inverted duplication.";
RL   Stem Cell Res. 34:101377-101377(2019).
//